or Try an Advanced Search...

    Technical Analysis for TNYA - Tenaya Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 2.22 -2.20% -0.05
    TNYA closed down 2.2 percent on Wednesday, November 20, 2024, on 1.9 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical TNYA trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Shooting Star Candlestick Bearish -2.20%
    Crossed Above 20 DMA Bullish -2.20%
    Stochastic Buy Signal Bullish -2.20%
    Volume Surge Other -2.20%
    Doji - Bearish? Reversal -2.20%
    Wide Bands Range Expansion -2.20%
    Older End-of-Day Signals for TNYA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 17 hours ago
    60 Minute Opening Range Breakdown about 18 hours ago
    Down 2 % about 18 hours ago
    Down 1% about 18 hours ago
    Fell Below 10 DMA about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TNYA Chart by TradingView
    Basic chart:

    Profile

    Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Gene Therapy Biomarkers Heart Failure Heart Disease Personalized Medicine Induced Stem Cells Chemical Pathology

    Is TNYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    Nov 7 Tenaya Therapeutics GAAP EPS of -$0.30
    Nov 6 Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 3 Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
    Nov 1 Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation
    Oct 17 Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
    Sep 21 Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA),
    Sep 3 Tenaya Therapeutics to Participate in Upcoming Investment Conferences
    Aug 9 Tenaya Therapeutics GAAP EPS of -$0.34
    Aug 8 Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
    See more TNYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.01
    52 Week Low 1.61
    Average Volume 2,472,657
    200-Day Moving Average 3.56
    50-Day Moving Average 2.01
    20-Day Moving Average 2.16
    10-Day Moving Average 2.27
    Average True Range 0.31
    RSI (14) 52.38
    ADX 33.22
    +DI 32.26
    -DI 16.64
    Chandelier Exit (Long, 3 ATRs) 2.21
    Chandelier Exit (Short, 3 ATRs) 2.74
    Upper Bollinger Bands 2.63
    Lower Bollinger Band 1.68
    Percent B (%b) 0.57
    BandWidth 44.22
    MACD Line 0.04
    MACD Signal Line 0.05
    MACD Histogram -0.0104
    Fundamentals Value
    Market Cap 151.21 Million
    Num Shares 68.1 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -1.19
    Price-to-Sales 0.00
    Price-to-Book 2.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.66
    Resistance 3 (R3) 2.69 2.57 2.58
    Resistance 2 (R2) 2.57 2.46 2.56 2.56
    Resistance 1 (R1) 2.40 2.39 2.34 2.37 2.53
    Pivot Point 2.28 2.28 2.26 2.27 2.28
    Support 1 (S1) 2.11 2.17 2.05 2.08 1.91
    Support 2 (S2) 1.99 2.10 1.98 1.88
    Support 3 (S3) 1.82 1.99 1.86
    Support 4 (S4) 1.79